Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- Biomolecular NMR Assignments : The 1H, 15N and 13C backbone resonance assignments of an intrinsically disordered region (467–696) of breast cancer type 1 susceptibility protein (BRCA1) (Sung, Libich)
- Cell Reports: EWSR1::FLI1 promotes neocentromere formation in Ewing sarcoma cells (Kitagawa, Zheng, & Sung Labs)
- 🎗️ Childhood Cancer Awareness Month may be ending. The work is not.
- Childhood Cancer Awareness Month: 🎗️ THE SCIENCE BEHIND THE GOLD RIBBON: THE HISTOLOGY CORE
- Childhood Cancer Awareness Month🎗️:The Science Behind the Gold Ribbon: Xenograft & Cell-Lines Core
Events
Greehey CCRI Seminar Series – Fall ’26: Jeanne Stachowiak, PhD (UT Austin)
Presentation title: Intrinsic Disorder as an Organizing Principle for Cellular Membranes
Greehey CCRI Fall ’26 Seminar Series: Reuben Harris, PhD (UTHSA)
Presentation title: “Progress on the development of novel drugs for viral proteases”
Greehey CCRI Seminar Series – Fall ’26 Elif Sarinay Cenik, PhD (UT Austin)
Presentation title: How Ribosome Nucleolar Defects Create Metabolic and Chromatin Vulnerabilities